Zurich – CFI Switzerland is pleased to announce that they supported Bioforce AG, Switzerland in the acquisition of the shares it did not already own in the joint venture with Bioforce Denmark A/S, Denmark. Prior to closing the transaction, Bioforce AG had a minority interest in Bioforce Denmark A/S.
Bioforce AG develops and produces phytopharmaceuticals, nutraceuticals and food supplements for international distribution. Besides its products, the philosophy of Bioforce is to focus on comprehensive and well-founded information on health topics. Bioforce has 350 employees and generates sales of approx. CHF 110 m.
Bioforce Denmark A/S is the exclusive distributor of Bioforce products in Denmark. The company is run by the founder and owner.
The parties agreed not to disclose further transaction details.
The transaction closed on 1 January 2019.
The owners of
have sold a
Owners of Rhythmlink International, LLC, a leading full-service designer, manufacturer, and distributor of neurodiagnostic devices, consumables, and solutions, sold a majority stake of the Company to raise growth capital
has been sold to
Careflex Zorg Groep, the largest independent external healthcare provider for complex care with a proven and distinct BPO proposition in the Benelux, has been sold to Bolster Investment Partners
acquired a majority stake in
Ergon Capital Partners has acquired a majority stake in Indo Optical, a leading Spanish independent manufacturer of ophtalmic lenses and distributor of optical and ophtalmologic equipment
has made a collection of Euro 50 million in form of Acquistion Financing
CEF, a leading italian wholesale distirbutor of pharmaceuticals products to Italian pharmacies, has made a collection of Euro 50 million in form of Acquistion Financing.